NS 031
Alternative Names: NS-031Latest Information Update: 23 Jan 2025
Price :
$50 *
At a glance
- Originator NeuShen Therapeutics
- Class Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Depressive disorders
Most Recent Events
- 08 Jan 2025 Preclinical trials in Depressive disorders in China (unspecified route) before January 2025 (NeuShen Therapeutics pipeline, January 2025)